市場調査レポート

医療画像用試薬市場(クラス別:造影剤用試薬、光学的試薬、核医学用試薬、技術別:ナノ粒子、蛍光タンパク質、蛍光染料およびプローブ、放射性医薬品および量子ドット、および応用別:診断、創薬開発、および研究開発) - 世界業界分析、市場規模、シェア、成長、動向および予測

Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 305306
出版日 ページ情報 英文 103 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
医療画像用試薬市場(クラス別:造影剤用試薬、光学的試薬、核医学用試薬、技術別:ナノ粒子、蛍光タンパク質、蛍光染料およびプローブ、放射性医薬品および量子ドット、および応用別:診断、創薬開発、および研究開発) - 世界業界分析、市場規模、シェア、成長、動向および予測 Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年05月28日 ページ情報: 英文 103 Pages
概要

世界的に癌や心血管疾患を患う患者数が急増していることから、医療画像用試薬市場の成長が促進されています。医療画像用試薬は診断や医薬品、バイオテクノロジー、ライフサイエンス業界で重要な役割を担っています。こうした試薬は、腫瘍が悪性か良性かを特定し、体内の転移部位の位置を知らせます。医療画像用試薬は画像システムを通じて画像を改良するためにつくられた化合物です。

当レポートでは、医療画像用試薬市場の2011〜2019年の動向予測、市場促進因子と阻害因子、市場の機会、地域別動向とともに、参入企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクションと市場の定義
  • 市場促進因子
    • 高齢人口の増加が市場の成長を促進
    • 癌、心血管疾患、脳神経疾患の罹患率の上昇が市場成長につながる
    • 画像診断処置の需要拡大が画像用試薬の売上に影響
    • 技術的進歩が画像用試薬市場の成長を促進
  • 市場阻害因子
    • 画像用試薬のサプライヤーの不足が市場の成長を阻害
    • 厳しい認可手続きが市場の成長を阻害
    • 核医学製品導入への躊躇が市場成長を制限
  • 市場の機会
    • 新興市場における流通網の強化
    • 核医学製品に基づく個別化治療の開発
  • ポーターズファイブフォース分析
  • 市場の魅力度分析
  • 市場シェア分析

第4章 世界の医療画像用試薬市場:クラス別

  • 概要
  • 造影剤用試薬
  • 光学的試薬
  • 核医学用試薬

第5章 世界の医療画像用試薬市場:技術別

  • 概要
  • ナノ粒子
  • 蛍光タンパク質
  • 蛍光塗料およびプローブ
  • 放射性医薬品
  • 量子ドット

第6章 世界の医療画像用試薬市場:用途別

  • 概要
  • 診断
  • 創薬開発
  • 研究開発

第7章 世界の医療画像用試薬市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第8章 提言

  • 成功のための市場戦略
  • 検討すべき障壁

第9章 企業プロファイル

  • Bayer Healthcare AG
  • Beckman Coulter, Inc.
  • Becton Dickinson & Company
  • Bracco Imaging SpA
  • Cardinal Health, Inc.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt Pharmaceuticals
  • Promega Corporation
  • Siemens Healthcare
  • Thermo Fisher Scientific, Inc.
目次

Title: Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Full Title:Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

A surge in the number of cancer and cardiovascular patients globally has prompted the growth of the medical imaging reagents market. Medical imaging reagents play a significant role in diagnostic, pharmaceuticals, biotechnology medical and life science industries. These reagents allow clinicians and healthcare providers to determine whether a tumor is malignant or benign and enables to locate any metastatic cancerous sites in the body. Medical imaging reagents are specially designed chemical compounds used to enhance images produced through imaging systems.

The medical imaging reagents market has been primarily segmented by class, technology and applications. On the basis of product class, the medical imaging reagents market comprises contrast reagents, optical reagents and nuclear reagents. Moreover, the technology segment of this market includes nanoparticles, fluorescent proteins, radiopharmaceuticals, quantum dots, fluorescent dyes and probes. Furthermore, applications market for medical imaging reagents consists of diagnostics, drug discovery and development as well as research and development. The market analysis of the above segments in terms of revenue and forecast (USD Million) has been provided in this report for the period 2011 - 2019. Moreover, this report also includes the respective compounded annual growth rate (CAGR %) for the above segments for the period 2013 - 2019, considering 2012 as the base year.

This research report on medical imaging reagents helps in understanding various market dynamics, such as the drivers, restraints and opportunities responsible for market growth. The market overview section of the report also includes qualitative analysis such as market attractiveness analysis and Porter's five forces model which assist in understanding the overall competition prevalent in the market.

The research report provides in-depth analysis of the medical imaging reagents market in major geographies such as North America, Europe, Asia and RoW. The market revenue and forecast for all the four regional markets for the period 2011 - 2019 along with their respective CAGRs are also included in this report. The report provides company profiles of major players in the market. Additionally, detailed market share analysis has been provided of the leading players along with strategic recommendations for the new market entrants and the existing market players. Some of the major market players profiled in this report include Bayer Healthcare AG, Bracco Imaging SpA, GE Healthcare, Lantheus Medical Imaging, Inc., Mallinckrodt Pharmaceuticals, Siemens Healthcare, Thermo Fisher Scientific, Inc. and others.

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Sources
    • 1.3.2. Assumptions

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Medical Imaging Reagents Market

Chapter 3 - Market Overview

  • 3.1. Introduction and Market Definition
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers
      • 3.2.1.1. Growing number of elderly population expected to drive market growth
      • 3.2.1.2. Increasing prevalence rate of cancer, cardiovascular and neurological diseases expected to trigger market growth
      • 3.2.1.3. Escalating demand for diagnostic imaging procedures influences imaging reagents sales
      • 3.2.1.4. Technological development likely to spur the growth of the imaging reagents market
    • 3.2.2. Market Restraints
      • 3.2.2.1. Shortage of supplies of imaging reagents impede the growth of the market
      • 3.2.2.2. Stringent regulatory approvals likely to hamper the market growth
      • 3.2.2.3. Reluctance in adopting nuclear products restrict the market growth
    • 3.2.3. Market Opportunities
      • 3.2.3.1. Strengthening distribution network in emerging markets
      • 3.2.3.2. Development of nuclear products based personalized therapy
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Bargaining Power of Buyers
    • 3.3.3. Threat of New Entrants
    • 3.3.4. Threat of Substitutes
    • 3.3.5. Competitive Rivalry
  • 3.4. Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
  • 3.5. Market Share Analysis for Global Medical Imaging Reagents, by Key Players, 2012 (Value %)

Chapter 4 - Global Medical Imaging Reagents Market, by Class

  • 4.1. Overview
    • 4.1.1. Global Medical Imaging Reagents Market Revenue, by Class, 2011 - 2019 (USD Million)
  • 4.2. Contrast Reagents
    • 4.2.1. Global Contrast Reagents Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Optical Reagents
    • 4.3.1. Global Optical Reagents Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Nuclear Reagents
    • 4.4.1. Global Nuclear Reagents Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Global Medical Imaging Reagents Market, by Technology

  • 5.1. Overview
    • 5.1.1. Global Medical Imaging Reagents Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • 5.2. Nanoparticles
    • 5.2.1. Global Nanoparticles Market Revenue, 2011 - 2019 (USD Million)
  • 5.3. Fluorescent Proteins
    • 5.3.1. Global Fluorescent Proteins Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Fluorescent Dyes and Probes
    • 5.4.1. Global Fluorescent Dyes and Probes Market Revenue, 2011 - 2019 (USD Million)
  • 5.5. Radiopharmaceuticals
    • 5.5.1. Global Radiopharmaceuticals Market Revenue, 2011 - 2019 (USD Million)
  • 5.6. Quantum Dots
    • 5.6.1. Global Quantum Dots Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Global Medical Imaging Reagents Market, by Application

  • 6.1. Overview
    • 6.1.1. Global Medical Imaging Reagents Market Revenue, by Application, 2011 - 2019 (USD Million)
  • 6.2. Diagnostics
    • 6.2.1. Global Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Drug Discovery and Development
    • 6.3.1. Global Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Research and Development
    • 6.4.1. Global Research and Development Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Global Medical Imaging Reagents Market, by Geography

  • 7.1. Overview
    • 7.1.1. Global Medical Imaging Reagents Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • 7.5. Rest of the World (RoW)
    • 7.5.1. RoW Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)

Chapter 8 - Recommendations

  • 8.1. Market Strategy for Success
  • 8.2. Barriers to be Considered

Chapter 9 - Company Profiles

  • 9.1. Bayer Healthcare AG
    • 9.1.1. Company Overview
    • 9.1.2. Financial Overview
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategies
    • 9.1.5. Recent Developments
  • 9.2. Beckman Coulter, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. Becton Dickinson & Company
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
  • 9.4. Bracco Imaging SpA
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Cardinal Health, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. Lantheus Medical Imaging, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. Mallinckrodt Pharmaceuticals
    • 9.7.1. Company Overview
    • 9.7.2. Financial Overview
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategies
    • 9.7.5. Recent Developments
  • 9.8. Promega Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. Siemens Healthcare
    • 9.9.1. Company Overview
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. Thermo Fisher Scientific, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Overview
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategies
    • 9.10.5. Recent Developments

List of Figures

  • FIG. 1: Medical Imaging Reagents Market Segmentation
  • FIG. 2: Global Medical Imaging Reagents Market, by Class, 2012 (USD Million)
  • FIG. 3: Global Medical Imaging Reagents Market, by Technology, 2012 (USD Million)
  • FIG. 4: Global Medical Imaging Reagents Market, by Application, 2012 (USD Million)
  • FIG. 5: Comparative Analysis: Global Medical Imaging Reagents Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 6: Global Medical Imaging Reagents Market: Drivers and Restraints
  • FIG. 7: Porter's Five Forces Analysis: Global Medical Imaging Reagents Market
  • FIG. 8: Market Attractiveness Analysis: Global Medical Imaging Reagents Market, by Geography
  • FIG. 9: Market Share Analysis: Global Medical Imaging Reagents Market, by Key Players, 2012 (Value %)
  • FIG. 10: Global Contrast Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Optical Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Nuclear Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Nanoparticles Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Fluorescent Proteins Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: Global Fluorescent Dyes and Probes Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Global Radiopharmaceuticals Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: Global Quantum Dots Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: Global Diagnostics Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19: Global Drug Discovery and Development Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 20: Global Research and Development Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 21: North America Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 22: Europe Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 23: Asia-Pacific Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 24: RoW Medical Imaging Reagents Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 25: Bayer Healthcare AG, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 26: Becton, Dickinson and Company, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 27: Cardinal Health, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 28: Lantheus Medical Imaging, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 29: Mallinckrodt Pharmaceuticals, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 30: Siemens Healthcare, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 31: Thermo Fisher Scientific, Inc., Annual Revenue: 2010 - 2012 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: Global Medical Imaging Reagents Market
  • TABLE 2: Global Medical Imaging Reagents Market Revenue, by Class, 2011 - 2019 (USD Million)
  • TABLE 3: Global Medical Imaging Reagents Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 4: Global Medical Imaging Reagents Market Revenue, by Application, 2011 - 2019 (USD Million)
  • TABLE 5: Global Medical Imaging Reagents Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top